Biotech

Latest Articles

Chinese the hormone insulin producer's GLP-1 tops Ozempic in ph. 2

.Chinese blood insulin creator Gan &amp Lee Pharmaceuticals is actually falling to the being overwei...

Teva uses biotech principles as it leans right into impressive medicine development, director claims

.Amid a reorganization campaign that's revived combination general and impressive medications player...

Eli Lilly unveils 2 brand-new research centers in China

.Eli Lilly is actually growing its advancement digs to Beijing, China, opening 2 research centers na...

J &amp J jettisons numerous plans, including ph. 2 Alzheimer's job

.Johnson &amp Johnson is actually rejecting a number of systems, along with 3 of the culls happening...

New biotech intentions to improve thymus Tolerance

.Cell treatment biotech Sensitivity Biography has actually revealed with $17.2 million as well as an...

Lundbeck signs $2.5 B look for Longboard and also its own epilepsy med

.After spying runaway success possibility in Longboard Pharmaceuticals' epilepsy med, brain disease-...

Lilly decides on UK for first Portal Laboratory in Europe

.Eli Lilly's Portal Labs is actually going worldwide, along with the U.K. federal government introdu...

Jasper dials up dose after colonies actions reoccur swiftly

.Jasper Therapy has actually stated full responses in 10 of the 12 persistent colonies patients who ...

Transgene's popular cancer cells vaccine flunks midphase test

.Transgene's restorative vaccine candidate TG4001 has actually flunked a phase 2 sound growth test. ...

Upstream swells IPO to $255M as it provides alongside CAMP4

.Upstream Biography possesses puffy its IPO to $255 million as the firm signs up with CAMP4 Therapie...

Sanofi flunks MS research, giving an additional strike to Denali treaty

.Sanofi has ceased a phase 2 ordeal of Denali Therapeutics-partnered oditrasertib in numerous sclero...

Turnstone lays off 60%, shakes up C-suite to stretch out cash money

.Turnstone Biologics is decreasing its headcount through 60% and also agitating its C-suite in order...

Gilead quits on $15M MASH wager after reviewing preclinical data

.In a year that has found a permission and a raft of readouts for metabolic dysfunction-associated s...

Texas biotech axes cancer treaty, pins wishes on obesity

.Alaunos Rehabs is axing an arrangement along with Precigen, surrendering licensing civil liberties ...

Capricor shares much more data for DMD treatment after triggering BLA

.Capricor Therapies is actually taking a triumph tour for their stage 2 Duchenne muscular dystrophy ...

FDA places Kezar lupus trial in grip observing 4 person deaths

.The FDA has placed Kezar Life Sciences' lupus trial on hold after the biotech hailed 4 deaths durin...

Phase 3 Historian Stone test attacks SMA target, sending out stock up 200%

.A stage 3 trial of Intellectual Stone's spine muscle degeneration (SMA) applicant has reached its k...

CAMP 4 is most up-to-date to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Rehabs has defined plans for a $67 thousand IPO, with inflammation-focused Upstre...

Galecto buys leukemia medication, goes down bone tissue cancer possession in pivot

.A year after the failing of an idiopathic pulmonary fibrosis prospect delivered Galecto on a seek r...

Judo tosses down $100M to knock senseless renal disease

.Taking the floor covering is actually Judo Biography, an up-and-coming biotech equipped along with ...